GLP-1s 101: What the Science Says About Weight Loss, Side Effects, and Safety
Stanford Medicine experts break down everything you need to know about the drugs known as GLP-1s, semaglutide, Ozempic, Wegovy, Zepbound, and many more.
Big Ideas in Medicine Conference
Join conversations with thought leaders from academia, business, policy, and journalism as they present their big ideas that will shape the future of medicine.
GLP-1s 101: What the Science Says About Weight Loss, Side Effects, and Safety
Stanford Medicine experts break down everything you need to know about the drugs known as GLP-1s, semaglutide, Ozempic, Wegovy, Zepbound, and many more.
A Pancreatic Cancer Drug Provides New Hope: Five Things to Know About Daraxonrasib
Hundreds of thousands of new cancer studies come out every year. Why are the results from a drug called daraxonrasib causing waves in the research community?
The Facts About Fiber: What Stanford Medicine Experts Want You to Know
Dietary fiber feeds your microbiome and helps keep things moving on the regular, but most of us aren’t getting nearly enough of this unsung nutrient.
Now Available: Season Three
Tune in as we bring the latest medical research to life through compelling stories that connect with your everyday health experiences.
IN THE NEWS
Stanford Health Care is one of a few centers in the world to offer this treatment, which offers a viable surgical alternative to radical resection.
IN THE NEWS
Stanford Medicine researchers have devised a way to see exactly where in a tumor antibody drugs are located, and even which cells they are binding to—an order of resolution many times better than current methods.
IN THE NEWS
Liao, the Kathryn Simmons Stamey Professor and professor of urology, is an accomplished physician-scientist, urologic surgeon and educator who is nationally recognized for his contributions to precision diagnostics for major urological diseases, particularly bladder cancer, his primary clinical focus.
